Physician
Internal Medicine
Dr. Dana A. Swenson, MD
|
|
Give Review
Dr. Dana A. Swenson practices Internal Medicine. She graduated from University of Minnesota Medical School. University of Minnesota Medical School has a rank of 40 in research and a 10 in primary care She has 4 awards "CMS Meaningful Use Stage 1 Certification", "Physician Practice Connections Recognition Program", "Diabetes Recognition Program" and "Patient-Centered Medical Home Recognition Program". Dana Swenson is also published. She has 28 publications published. The lastest publication: "Two pathogenicity islands in uropathogenic Escherichia coli J96: cosmid cloning and sample sequencing.' Dana A. Swenson is registered with Medicare and accepts Medicare payments.
Publications
- Homologous and heterologous protection of nonhuman primates by ebola and Sudan virus-like particles.
- Identification of ancillary fim genes affecting fimA expression in Salmonella typhimurium.
- Two pathogenicity islands in uropathogenic Escherichia coli J96: cosmid cloning and sample sequencing.
- Battling against host phagocytes: the wherefore of the RTX family of toxins?
- Evaluation of the Cepheid GeneXpert system for detecting Bacillus anthracis.
- Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis.
- Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
- Advanced antisense therapies for postexposure protection against lethal filovirus infections.
- Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection.
- Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
- Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.
- Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
- Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents.
- Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent.
- Involvement of vacuolar protein sorting pathway in Ebola virus release independent of TSG101 interaction.
- NKp30-dependent cytolysis of filovirus-infected human dendritic cells.
- Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.
- VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.
- Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.
- Filovirus-like particles as vaccines and discovery tools.
- Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection.
- Analysis of Ebola virus and VLP release using an immunocapture assay.
- Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
- Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation.
- Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
- Role of natural killer cells in innate protection against lethal ebola virus infection.
- Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein.
Schools
University Of Minnesota Medical School
University of Washington
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Physician Practice Connections Recognition Program
- Diabetes Recognition Program
- Patient-Centered Medical Home Recognition Program
Education
-
University of Washington -
University of Minnesota Medical School
Hospital
-
EvergreenHealth -
Virginia Mason Medical Center
Drug Facts
| NPI NUMBER | 1609865898 | |
| NPPES Provider LastName | SWENSON | |
| NPPES Provider FirstName | DANA | |
| NPPES Provider ZIPCode | 980342954 | |
| NPPES Provider State | WA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 3113.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 122.0 | |
| Percent Opioid Claims | 3.92 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609865898 |
| Last Name Of The Provider | SWENSON |
| First Name Of The Provider | DANA |
| View All |
Similar Doctors
|
|
Dr. Barbara J. Troiano, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Stephen N. Aprill, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael Mena, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard M. Furlong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Murray A. Beighton, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Tony Yen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David A. Baker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jared W. Remington, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scott R. Stuart, MD |
|
|
Dr. Catherine Booms, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Yun Suhr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Reid, MD |
|
Dr. Ettore G. Palazzo, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michelle L. Gordon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hjordis M. Foy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jill C. Mosby, MD
This Doctor is OpenDoctor Recommended.
|